ankylosing spondylitis activity, not due to treatment interruption or poor adherence, after having a sustained clinically meaningful improvement on treatment (generally, beyond the initial 6 months of treatment). Conventional synthetic antirheumatic drug Sulfasalazine, methotrexate, leflunomide, apremilast, thalidomide, pamidronate. Biosimilar Biopharmaceuticals that are copies of an original biologic medication and tested to be of the same purity and potency as the original. In these